menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    In 2014, the CDC estimated a total of 2,194 cases of acute hepatitis across 40 states and estimates that 2.7-3.9 million people in the United States have chronic hepatitis C.  Of every 100 persons affected by the disease, 75 to 85 will go on to develop chronic infection, 60 to 70 will go on to develop chronic liver disease, 5 to 20 will go on to develop cirrhosis over a period of 20–30 years, and 1 to 5 will die from the consequences of chronic infection (liver cancer or cirrhosis).  

    Joining our host, Dr. Jennifer Caudle, is Dr. Vincent Lo Re, Assistant Professor of Medicine and Infectious Diseases and Epidemiology at Penn Medicine. Dr. Lo Re discusses the current screening guidelines and recommendations regarding hepatitis C, long-term patient care, and the current landscape of treatment options. 

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    In 2014, the CDC estimated a total of 2,194 cases of acute hepatitis across 40 states and estimates that 2.7-3.9 million people in the United States have chronic hepatitis C.  Of every 100 persons affected by the disease, 75 to 85 will go on to develop chronic infection, 60 to 70 will go on to develop chronic liver disease, 5 to 20 will go on to develop cirrhosis over a period of 20–30 years, and 1 to 5 will die from the consequences of chronic infection (liver cancer or cirrhosis).  

    Joining our host, Dr. Jennifer Caudle, is Dr. Vincent Lo Re, Assistant Professor of Medicine and Infectious Diseases and Epidemiology at Penn Medicine. Dr. Lo Re discusses the current screening guidelines and recommendations regarding hepatitis C, long-term patient care, and the current landscape of treatment options. 

Facebook Comments

Schedule8 Dec 2021
Webpack App